The regulation of HIV-1 gene expression: The emerging role of chromatin

DNA and Cell Biology

Volumn 21, Issue 10, 2002, Pages 697-705

  He, Guocheng ^a   Ylisastigui, Loyda ^a   Margolis, David M ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Department of Cell and Molecular Biology ^*  (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; RNA POLYMERASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VPR PROTEIN;

CELL FUNCTION; CHROMATIN; CHROMATIN STRUCTURE; DNA INTEGRATION; DNA TRANSCRIPTION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REPRESSOR GENE; REVIEW; TRANSCRIPTION REGULATION; VIRUS GENE; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036436703     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454902760599672     Document Type: Review

References (102)

1. Adler, S., Waterman, M.L., He, X., and Rosenfeld, M.G. (1988). Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell 52, 685-695.
2. Ahmad, N., and Venkatesan, S. (1988). Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485.
3. Alonso, A., Cujec, T.P., and Peterlin, B.M. (1994). Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J. Virol. 68, 6505-6513.
4. Alonso, A., Derse, D., and Peterlin, B.M. (1992). Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol. 66, 4617-4621.
5. Annunziato, A.T., Eason, M.B., and Perry, C.A. (1995). Relationship between methylation and acetylation of arginine-rich histones in cycling and arrested HeLa cells. Biochemistry 34, 2916-2924.
6. Bachelerie, F., Alcami, J., Hazan, U., Israel, N., Goud, B., Arenzana-Seisdedos, F., and Virelizier, J.L. (1990). Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. J. Virol. 64, 3059-3062.
7. Benkirane, M., Chun, R.F., Xiao, H., Ogryzko, V.V., Howard, B.H., Nakatani, Y., and Jeang, K.T. (1998). Activation of integrated provims requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273, 24898-24905.
8. Berkhout, B., Silverman, R.H., and Jeang, K.T. (1989). Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59, 273-282.
9. Brown, D.A., Xu, X., and Nerenberg, M. (1996). Genomic footprinting of HTLV type I and HIV type 1 in human T cell lines. AIDS Res. Hum. Retroviruses 12, 829-832.
10. Carteau, S., Hoffmann, C., and Bushman, F. (1998). Chromosome structure and human immunodeficiency virus type 1 cDNA integration: Centromeric alphoid repeats are a disfavored target. J. Virol. 72, 4005-4014.
11. Chen, D., Ma, H., Hong, H., Koh, S.S., Huang, S.M., Schurter, B.T., Aswad, D.W., and Stallcup, M.R. (1999). Regulation of transcription by a protein methyltransferase. Science 284, 2174-2177.
12. Cheung, P., Tanner, K.G., Cheung, W.L., Sassone-Corsi, P., Denu, J.M., and Allis, C.D. (2000). Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5, 905-915.
13. Chun, R.F., Semmes, O.J., Neuveut, C., and Jeang, K.T. (1998). Modulation of Spl phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72, 2615-2629.
14. Clayton, A.L., Rose, S., Barratt, M.J., and Mahadevan, L.C. (2000). Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19, 3714-3726.
15. Col, E., Caron, C., Seigneurin-Berny, D., Gracia, J., Favier, A., and Khochbin, S. (2001). The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J. Biol. Chem. 276, 28179-28184.
16. Cosma, M.P., Tanaka, T., and Nasmyth, K. (1999). Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle and developmentally regulated promoter. Cell 97, 299-311.
17. Coull, J.J., Romerio, F., Sun, J.M., Volker, J.L., Galvin, K.M., Davie, J.R., Shi, Y., Hansen, U., and Margolis, D.M. (2000). The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J. Virol. 74, 6790-6799.
18. Cron, R.Q., Bartz, S.R., Clausell, A., Bort, S.J., Klebanoff, S.J., and Lewis, D.B. (2000). NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clin. Immunol. 94, 179-191.
19. Demarchi, F., D'agaro, P., Falaschi, A., and Giacca, M. (1993). In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67, 7450-7460.
20. Deng, L., De La Fuente, C., Fu, P., Wang, L., Donnelly, R., Wade, J.D., Lambert, P., Li, H., Lee, C.G., and Kashanchi, F. (2000). Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277, 278-295.
21. Dickinson, L.A., Trauger, J.W., Baird, E.E., Dervan, P.B., Graves, B.J., and Gottesfeld, J.M. (1999). Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappaB, and DNA by a designed DNA-binding ligand. J. Biol. Chem. 274, 12765-12773.
22. Dingwall, C., Ernberg, I., Gait, M.J., Green, S.M., Heaphy, S., Karn, J., Lowe, A.D., Singh, M., Skinner, M.A., and Valerio, R. (1989). Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86, 6925-6929.
23. Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, G., Wintersberger, E., and Seiser, C. (1999). Histone deacetylase 1 can repress transcription by binding to Spl. Mol. Cell. Biol. 19, 5504-5511.
24. El Kharroubi, A., Piras, G., Zensen, R., and Martin, M.A. (1998). Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 18, 2535-2544.
25. El Kharroubi, A., and Verdin, E. (1994). Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269, 19916-19924.
26. Felsenfeld, G. (1996). Chromatin unfolds. Cell 86, 13-19.
27. Flaus, A., and Owen-Hughes, T. (2001). Mechanisms for ATP-dependent chromatin remodeling. Curr. Opin. Genet. Dev. 11, 148-154.
28. Fryer, C.J., and Archer, T.K. (1998). Chromatin remodeling by the glucocorticoid receptor requires the BRG1 complex. Nature 393, 88-91.
29. Galvin, K.M., and Shi, Y. (1997). Multiple mechanisms of transcriptional repression by YY1. Mol. Cell. Biol. 17, 3723-3732.
30. Gatignol, A., Kumar, A., Rabson, A., and Jeang, K.T. (1989). Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA. Proc. Natl. Acad. Sci. USA 86, 7828-7832.
31. Gaynor, R. (1992). Cellular transcription factors involved in the regulation of HIV-1 gene expression. Aids 6, 347-363.
32. Goh, W.C., Rogel, M.E., Kinsey, C.M., Michael, S.F., Fultz, P.N., Nowak, M.A., Hahn, B.H., Emerman, M. (1998). HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 4, 65-71.
33. Gummuluru, S., and Emerman, M. (1999). Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J. Virol. 73, 5422-5430.
34. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
35. Hanna-Rose, W., and Hansen, U. (1996). Active repression mechanisms of eukaryotic transcription repressors. Trends Genet. 12, 229-234.
36. He, G., and Margolis, D.M. (2002). Counter-regulation of chromatin acetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 by the HIV-1 activator Tat and the HIV-1 repressor YY1. Mol. Cell. Biol. 22, 2965-2973.
37. Herrmann, C.H., and Rice, A.P. (1993). Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197, 601-608.
38. Huang, L.M., and Jeang, K.T. (1993). Increased spacing between Spl and TATAA renders human immunodeficiency virus type 1 replication defective: Implication for Tat function. J. Virol. 67, 6937-6944.
39. Jaynes, J.B., and O'farrell, P.H. (1991). Active repression of transcription by the engrailed homeodomain protein. EMBO J. 10, 1427-1433.
40. Jeang, K.T., Chun, R., Lin, N.H., Gatignol, A., Glabe, C.G., and Fan, H. (1993). In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Spl transcription factor. J. Virol. 67, 6224-6233.
41. Johnson, A.D., and Herskowitz, I. (1985). A repressor (MAT alpha 2 Product) and its operator control expression of a set of cell type specific genes in yeast. Cell 42, 237-247.
42. Jones, K.A., and Kadonaga, J.T. (2000). Exploring the transcription-chromatin interface, Genes Dev. 14, 1992-1996.
43. Jones, K.A., Kadonaga, J.T., Luciw, P.A., and Tjian, R. (1986). Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232, 755-759.
44. Jones, K.A., Luciw, P.A., and Duchange, N. (1988). Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev. 2, 1101-1114.
45. Jordan, A., Defechereux, P., and Verdin, E. (2001). The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 20, 1726-1738.
46. Kamine, J., and Chinnadurai, G. (1992). Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J. Virol. 66, 3932-3936.
47. Kao, S.Y., Calman, A.F., Luciw, P.A., and Peterlin, B.M. (1987). Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330, 489-493.
48. Kato, H., Horikoshi, M., and Roeder, R.G. (1991). Repression of HIV-1 transcription by a cellular protein. Science 251, 1476-1479.
49. Kiernan, R.E., Vanhulle, C., Schiltz, L., Adam, E., Xiao, H., Maudoux, F., Calomme, C., Burny, A., Nakatani, Y., Jeang, K.T., et al. (1999). HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18, 6106-6118.
50. Kinoshita, S., Chen, B.K., Kaneshima, H., and Nolan, G.P. (1998). Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95, 595-604.
51. Knezetic, J.A., and Luse, D.S. (1986). The presence of nucleosomes on a DNA template prevents initiation by RNA polymerase II in vitro. Cell 45, 95-104.
52. Krebs, J.E., Kuo, M.H., Allis, C.D., and Peterson, C.L. (1999). Cell cycle-regulated histone acetylation required for expression of the yeast HO gene. Genes Dev. 13, 1412-1421.
53. Kretzschmar, M., Meisterernst, M., Scheidereit, C., Li, G., and Roeder, R.G. (1992). Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev. 6, 761-774.
54. Levine, M., and Manley, J.L. (1989). Transcriptional repression of eukaryotic promoters. Cell 59, 405-408.
55. Liu, Y.Z., and Latchman, D.S. (1997). The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat. Biochem. J. 322, 155-158.
56. Mack, D.H., Vartikar, J., Pipas, J.M., and Laimins, L.A. (1993). Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363, 281-283.
57. Mahadevan, L.C., Willis, A.C., and Barratt, M.J. (1991). Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65, 775-783.
58. Marzio, G., Tyagi, M., Gutierrez, M.I., and Giacca, M. (1998). HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter, Proc. Natl. Acad. Sci. USA 95, 13519-13524.
59. Mouzaki, A., Doucet, A., Mavroidis, E., Muster, L., and Rungger, D. (2000). A repression-derepression mechanism regulating the transcription of human immunodeficiency virus type 1 in primary T cells. Mol. Med. 6, 377-390.
60. Natesan, S., and Gilman, M.Z. (1993). DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev. 7, 2497-2509.
61. Ott, M., Schnolzer, M., Garnica, J., Fischle, W., Emiliani, S., Rackwltz, H.R., and Verdin, E. (1999). Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9, 1489-1492.
62. Pazin, M.J., and Kadonaga, J.T. (1997). What's up and down with histone deacetylation and transcription? Cell 89, 325-328.
63. Pazin, M.J., Sheridan, P.L., Cannon, K., Cao, Z., Keck, J.G., Kadonaga, J.T., and Jones, K.A. (1996). NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10, 37-49.
64. Perkins, N.D., Agranoff, A.B., Pascal, E., and Nabel, G.J. (1994). An interaction between the DNA-binding domains of RelA(p65) and Spl mediates human immunodeficiency virus gene activation. Mol. Cell. Biol. 14, 6570-6583.
65. Perkins, N.D., Edwards, N.L., Duckett, C.S., Agranoff, A.B., Schmid, R.M., and Nabel, G.J. (1993). A cooperative interaction between NF-kappa B and Spl is required for HIV-1 enhancer activation. EMBO J. 12, 3551-3558.
66. Posada, R., Peti'Oello-Mantovani, M., Sieweke, M., Graf, T., and Goldstein, H. (2000). Suppression of HIV type 1 replication by a dominant-negative Ets-1 mutant. AIDS Res. Hum. Retroviruses 16, 1981-1989.
67. Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B.D., Sun, Z.W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C.P., Allis, C.D., and Jenuwein, T. (2000). Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599.
68. Rio, D., Robbins, A., Myers, R., and Tjian, R. (1980). Regulation of simian virus 40 early transcription in vitro by a purified tumor antigen. Proc. Natl. Acad. Sci. USA 77, 5706-5710.
69. Roebuck, K.A., and Saifuddin, M. (1999). Regulation of HIV-1 transcription. Gene Expr. 8, 67-84.
70. Romerio, F., Gabriel, M.N., and Margolis, D.M. (1997). Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF. J. Virol. 71, 9375-9382.
71. Rynditch, A.V., Zoubak, S., Tsyba, L., Tryapitsina-Guley, N., and Bernardi, G. (1998). The regional integration of retroviral sequences into the mosaic genomes of mammals. Gene 222, 1-16.
72. Sheppard, K.A., Rose, D.W., Haque, Z.K., Kurokawa, R., Mcinerney, E., Westin, S., Thanos, D., Rosenfeld, M.G., Glass, C.K., and Collins, T. (1999). Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 19, 6367-6368.
73. Sheridan, P.L., Mayall, T.P., Verdin, E., and Jones, K.A. (1997). Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11, 3327-3340.
74. Sheridan, P.L., Sheline, C.T., Cannon, K., Voz, M.L., Pazin, M.J., Kadonaga, J.T., and Jones, K.A. (1995). Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9, 2090-2104.
75. Shi, Y., Lee, J.S., and Galvin, K.M. (1997). Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, F49-F66.
76. Sieweke, M.H., Tekotte, H., Jarosch, U., and Graf, T. (1998). Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J. 17, 1728-1739.
77. Stanfield-Oakley, S.A., and Griffith, J.D. (1996). Nucleosomal arrangement of HIV-1 DNA: Maps generated from an integrated genome and an EBV-based episomal model. J. Mol. Biol. 256, 503-516.
78. Steger, D.J., and Workman, J.L. (1997). Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J 16, 2463-2472.
79. Steger, D.J., Eberharter, A., John, S., Grant, P.A., and Workman, J.L. (1998). Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc. Natl. Acad. Sci. USA 95, 12924-12929.
80. Strahl, B.D., and Allis, C.D. (2000). The language of covalent histone modifications. Nature 403, 41-45.
81. Strahl, B.D., Ohba, R., Cook, R.G., and Allis, C.D. (1999). Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl. Acad. Sci. USA 96, 14967-14972.
82. Struhl, K. (1996). Chromatin structure and RNA polymerase II connection: Implications for transcription. Cell 84, 179-182.
83. Struhl, K. (1998). Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606.
84. Struhl, K., and Moqtaderi, Z. (1998). The TAFs in the HAT. Cell 94, 1-4.
85. Sun, L.J., Peterson, B.R., and Verdine, G.L. (1997). Dual role of the nuclear factor of activated T cells insert region in DNA recognition and cooperative contacts to activator protein 1. Proc. Natl. Acad. Sci. USA 94, 4919-4924.
86. Sune, C., and Garcia-Blanco, M.A. (1995). Spl transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69, 6572-6576.
87. Tan, S.H., Leong, L.E., Walker, P.A., and Bernard, H.U. (1994). The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through the displacement of Spl and TFIID. J. Virol. 68, 6411-6420.
88. Thomson, S., Clayton, A.L., Hazzalin, C.A., Rose, S., Barratt, M.J., and Mahadevan, L.C. (1999). The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J. 18, 4779-4793.
89. Van Lint, C., Emiliani, S., Ott, M., and Verdin, E. (1996). Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15, 1112-1120.
90. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S., and Haegeman, G. (1999). The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274, 32091-32098.
91. Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., and Haegeman, G. (2000). Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 60, 1185-1195.
92. Vanitharani, R., Mahalingam, S., Rafaeli, Y., Singh, S.P., Srinivasan, A., Weiner, D.B., and Ayyavoo, V. (2001). HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. Virology 289, 334-342.
93. Verdin, E., Paras, P., JR., and Van Lint, C. (1993). Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12, 3249-3259.
94. Widlak, P., Gaynor, R.B., and Garrard, W.T. (1997). In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Spl and NFkappaB. J. Biol. Chem. 272, 17654-17661.
95. Wyrick, J.J., Holstege, F.C., Jennings, E.G., Causton, H.C., Shore, D., Grunstein, M., Lander, E.S., and Young, R.A. (1999). Chromosomal landscape ofnucleosome-dependent gene expression and silencing in yeast. Nature 402, 418-421.
96. Xiao, H., Hasegawa, T., and Isobe, K. (2000). p300 collaborates with Spl and Sp3 in p21(wafl/cipl) promoter activation induced by histone deacetylase inhibitor. J. Biol. Chem. 275, 1371-1376.
97. Yang, J., Kawai, Y., Hanson, R.W., and Arinze, I.J. (2001). Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Spl sites in the promoter and by activating the MEK-ERK signal transduction pathway. J. Biol. Chem. 276, 25742-25752.
98. Yang, W.M., Inouye, C., Zeng, Y., Bearss, D., and Seto, E. (1996). Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93, 12845-12850.
99. Yao, Y.L., Yang, W.M., and Seto, E. (2001). Regulation of transcription factor yyl by acetylation and deacetylation. Mol. Cell. Biol. 21, 5979-5991.
100. Yeung, K.C., Inostroza, J.A., Mermelstein, F.H., Kannabiran, C., and Reinberg, D. (1994). Structure-function analysis of the TBP-binding protein Drl reveals a mechanism for repression of class II gene transcription. Genes Dev. 8, 2097-2109.
101. Yew, P.R., Liu, X., and Berk, A.J. (1994). Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8, 190-202.
102. Zhong, F., Swendeman, S.L., Popik, W., Pitha, P.M., and Sheffery, M. (1994). Evidence that levels of the dimeric cellular transcription factor CP2 play little role in the activation of the HIV1 long terminal repeat in vivo or following superinfection with herpes simplex virus type 1. J. Biol. Chem. 269, 21269-21276.